Frank Podlaski

In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

Lyubomir T. Vassilev, Binh Thanh Vu, Bradford Graves et al. · Science · 2004 · 4.7K citations

Medicine, Oncology, Pharmacology +15

Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells.

A S Stern, Frank Podlaski, J D Hulmes et al. · Proceedings of the National Academy of Sciences · 1990 · 672 citations

Life Sciences, Biochemistry, Immunology +14

Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Development

Qingjie Ding, Zhuming Zhang, Jinjun Liu et al. · Journal of Medicinal Chemistry · 2013 · 597 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor)

Maurice K. Gately, B B Desai, A G Wolitzky et al. · The Journal of Immunology · 1991 · 462 citations · Full text

Life Sciences, Cell Biology, Immunology +7

Mouse interleukin‐12 (IL‐12) p40 homodimer: a potent IL‐12 antagonist

Silke Gillessen, Daisy Carvajal, Ping Ling et al. · European Journal of Immunology · 1995 · 435 citations

Life Sciences, Immunology, Immunoregulation +16